Justin shares his success with a novel treatment for non-Hodgkin lymphoma – NCI Center for Cancer Research

NCI Center for Cancer Research shared the following post on LinkedIn:

“Justin joined a CCR trial in 2020 and benefited from a novel 5-drug treatment called ViPOR for non-Hodgkin lymphoma. His doctor describes him as likely cancer-free.

‘I wouldn’t be here without NCI,’ Justin effused. ‘The NIH Clinical Center is one of the country’s best-kept secrets.’

Read his full story.”

Source: NCI Center for Cancer Research/LinkedIn